NEW YORK (GenomeWeb) – Enzo Life Sciences today announced it and Siemens Healthcare Diagnostics have agreed to settle a dispute alleging patent infringement. 

As part of the deal, Siemens will pay Enzo $9.5 million upfront. Enzo is also eligible to receive up to $5 million in licensing fees depending on the sale of additional Siemens products during a five-year period. In return, Enzo discharges Siemens from any claim of infringement of US Patent No. 7,064,197. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.